According to the Agency for Healthcare Quality, only 50-60% of VTE patients in the U.S. receive appropriate preventive treatment, even though compliance to best practices can stop as many as 70% of all hospital-acquired cases. Hospital-acquired VTE also creates unnecessary spending for providers, with the cost per episode estimated by ClinicoEconomics and Outcomes Research at $15,000. This number skyrockets to $82,000 for the one in five U.S. patients with VTE readmitted within 30 days.
2. Hospitals miss opportunities for VTE prevention
Providers face common barriers to making VTE prevention a higher priority, like lack of standardization, difficulty putting complicated guidelines into practice and general overwhelm with available information. As a result, hospitals miss these opportunities for VTE prevention:
- Assessing patients at admission (accounts for 30% of cases)
- Ordering appropriate VTE prophylaxis (accounts for 35% of cases)
- Educating patients (accounts for 15% of cases)
- Re-assessing for changes in patient risk levels (accounts for 20% of cases)
Looking to best practices – like implementing protocols with stronger assessments and consistently using proven clinical tools – can help the healthcare community overcome these barriers and reduce hospital-acquired blood clots.